16220-Ovarian Cancer-NA-421

Ovarian Cancer

A Phase II Open-Label Study of NUC-1031 in Patients with Platinum-Resistant Ovarian Cancer (PRO-105)

  • Details

ClinicalTrials.gov ID: NCT03146663
Diagnosis Type: NA
USOR Number: 16220

  • Address

433 SW 10th Street
Ocala, FL 34471
P: (352) 732-4032

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.